Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Recursion Pharmaceuticals Inc Share Price

RXRX

NSQ

$3.4

+$0.11

(3.34%)

Industry: Biotechnology Sector: Health Care

Recursion Pharmaceuticals Inc Analyst Forecast

Overview Returns Financials Ratios News FAQs

Recursion Pharmaceuticals Inc Share Price Chart

Recursion Pharmaceuticals Inc Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$1.74B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

12.18M

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.96

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$2.98 L

$7.18 H

$3.4

About Recursion Pharmaceuticals Inc, Common Stock

Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States and the United Kingdom. The company develops REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-617, which is in Phase 1/2 clinical trial to treat advanced solid tumors; REC-1245, which is in Phase 1/2 clinical trial to treat biomarker-enriched solid tumors and lymphoma; REC-3565 that is in Phase 1/2 for the treatment of relapsed or refractory B-cell malignancies; and REC-4539, a reversible, CNS penetrant, orally bioavailable, and potential best-in-class inhibitor of LSD1 for the treatment of solid tumors and hematology oncology. Its preclinical stage product includes REC-7735 for the treatment of HR+ breast cancer; and REC-102 for the treatment of hypophosphatasia. The company has collaboration and agreement with Roche & Genentech; Sanofi; Bayer AG; Tempus; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah. more

Industry: BiotechnologySector: Health Care

Recursion Pharmaceuticals Inc Stock Returns

Time Frame	RXRX	Sector	S&P500
1-Week Return	-7.06%	-2.44%	-2.28%
1-Month Return	-8.1%	-3.74%	-2.23%
3-Month Return	-24.02%	-2.53%	-2.29%
6-Month Return	-31.88%	8.72%	1.33%
1-Year Return	-46.68%	3.85%	19.22%
3-Year Return	-57.11%	19.83%	72.98%
5-Year Return	-89.49%	31.03%	69.03%

Time Frame	RXRX	Sector	S&P500
1-Week Return	-97.80%	-72.42%	-69.96%
1-Month Return	-64.22%	-37.11%	-24.00%
3-Month Return	-67.18%	-9.87%	-8.97%
6-Month Return	-54.09%	18.48%	2.72%
1-Year Return	-46.68%	3.85%	19.22%
3-Year Return	-24.59%	6.22%	20.04%
5-Year Return	-36.27%	5.55%	11.07%

Recursion Pharmaceuticals Inc Financials

	Dec '21	Dec '22	Dec '23	Dec '24	Dec '25	5YR TREND
Total Revenue	10.00M	39.68M	43.88M	58.84M	74.68M	[{"date":"2021-12-31","value":13.39,"profit":true},{"date":"2022-12-31","value":53.13,"profit":true},{"date":"2023-12-31","value":58.75,"profit":true},{"date":"2024-12-31","value":78.79,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Cost of Revenue	9.10M	48.27M	42.59M	45.24M	120.95M	[{"date":"2021-12-31","value":7.53,"profit":true},{"date":"2022-12-31","value":39.91,"profit":true},{"date":"2023-12-31","value":35.21,"profit":true},{"date":"2024-12-31","value":37.4,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Gross Profit	10.00M	(8.59M)	1.29M	13.60M	(46.27M)	[{"date":"2021-12-31","value":73.52,"profit":true},{"date":"2022-12-31","value":-63.19,"profit":false},{"date":"2023-12-31","value":9.48,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":-340.22,"profit":false}]
Gross Margin	100.00%	(21.66%)	2.94%	23.12%	(61.96%)	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-21.66,"profit":false},{"date":"2023-12-31","value":2.94,"profit":true},{"date":"2024-12-31","value":23.12,"profit":true},{"date":"2025-12-31","value":-61.96,"profit":false}]

Operating Expenses	192.78M	237.13M	351.35M	492.61M	601.86M	[{"date":"2021-12-31","value":32.03,"profit":true},{"date":"2022-12-31","value":39.4,"profit":true},{"date":"2023-12-31","value":58.38,"profit":true},{"date":"2024-12-31","value":81.85,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Operating Income	(182.78M)	(245.73M)	(350.06M)	(479.00M)	(648.13M)	[{"date":"2021-12-31","value":-18277500000,"profit":false},{"date":"2022-12-31","value":-24572700000,"profit":false},{"date":"2023-12-31","value":-35006000000,"profit":false},{"date":"2024-12-31","value":-47900400000,"profit":false},{"date":"2025-12-31","value":-64813200000,"profit":false}]
Total Non-Operating Income/Expense	(6.58M)	12.45M	36.12M	28.40M	24.21M	[{"date":"2021-12-31","value":-18.22,"profit":false},{"date":"2022-12-31","value":34.46,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":78.62,"profit":true},{"date":"2025-12-31","value":67.03,"profit":true}]
Pre-Tax Income	(186.48M)	(239.48M)	(332.13M)	(464.79M)	(644.89M)	[{"date":"2021-12-31","value":-18647900000,"profit":false},{"date":"2022-12-31","value":-23947600000,"profit":false},{"date":"2023-12-31","value":-33212800000,"profit":false},{"date":"2024-12-31","value":-46478800000,"profit":false},{"date":"2025-12-31","value":-64489500000,"profit":false}]
Income Taxes	(8.40M)	(55.00K)	(4.06M)	(1.13M)	(136.00K)	[{"date":"2021-12-31","value":-840500000,"profit":false},{"date":"2022-12-31","value":-5500000,"profit":false},{"date":"2023-12-31","value":-406200000,"profit":false},{"date":"2024-12-31","value":-112700000,"profit":false},{"date":"2025-12-31","value":-13600000,"profit":false}]
Income After Taxes	(178.07M)	(239.42M)	(328.07M)	(463.66M)	(644.76M)	[{"date":"2021-12-31","value":-17807400000,"profit":false},{"date":"2022-12-31","value":-23942100000,"profit":false},{"date":"2023-12-31","value":-32806600000,"profit":false},{"date":"2024-12-31","value":-46366100000,"profit":false},{"date":"2025-12-31","value":-64475900000,"profit":false}]

Income From Continuous Operations	(186.48M)	(239.48M)	(292.56M)	(463.66M)	(644.76M)	[{"date":"2021-12-31","value":-18647900000,"profit":false},{"date":"2022-12-31","value":-23947600000,"profit":false},{"date":"2023-12-31","value":-29256200000,"profit":false},{"date":"2024-12-31","value":-46366100000,"profit":false},{"date":"2025-12-31","value":-64475900000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income	(178.07M)	(239.42M)	(328.07M)	(463.66M)	(644.76M)	[{"date":"2021-12-31","value":-17807400000,"profit":false},{"date":"2022-12-31","value":-23942100000,"profit":false},{"date":"2023-12-31","value":-32806600000,"profit":false},{"date":"2024-12-31","value":-46366100000,"profit":false},{"date":"2025-12-31","value":-64475900000,"profit":false}]

EPS (Diluted)	(2.30)	(1.37)	(1.57)	(1.66)	(1.48)	[{"date":"2021-12-31","value":-230,"profit":false},{"date":"2022-12-31","value":-137,"profit":false},{"date":"2023-12-31","value":-157,"profit":false},{"date":"2024-12-31","value":-166,"profit":false},{"date":"2025-12-31","value":-148,"profit":false}]

	Dec '21	Dec '22	Dec '23	Dec '24	Dec '25	5YR TREND
Total Revenue	-	296.81%	10.57%	34.10%	26.92%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":3.56,"profit":true},{"date":"2024-12-31","value":11.49,"profit":true},{"date":"2025-12-31","value":9.07,"profit":true}]
Cost of Revenue	-	430.26%	(11.78%)	6.22%	167.37%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-2.74,"profit":false},{"date":"2024-12-31","value":1.45,"profit":true},{"date":"2025-12-31","value":38.9,"profit":true}]
Gross Profit	-	(185.94%)	(115.00%)	955.16%	(440.22%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-19.47,"profit":false},{"date":"2023-12-31","value":-12.04,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":-46.09,"profit":false}]
Gross Margin	-	(121.66%)	(113.56%)	686.83%	(368.05%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-17.71,"profit":false},{"date":"2023-12-31","value":-16.53,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":-53.59,"profit":false}]

Operating Expenses	-	23.01%	48.17%	40.20%	22.18%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":47.77,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":83.47,"profit":true},{"date":"2025-12-31","value":46.05,"profit":true}]
Operating Income	-	34.44%	42.46%	36.83%	35.31%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":81.12,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":86.75,"profit":true},{"date":"2025-12-31","value":83.16,"profit":true}]
Total Non-Operating Income/Expense	-	(289.12%)	190.15%	(21.38%)	(14.74%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-152.05,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-11.24,"profit":false},{"date":"2025-12-31","value":-7.75,"profit":false}]
Pre-Tax Income	-	28.42%	38.69%	39.94%	38.75%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":71.15,"profit":true},{"date":"2023-12-31","value":96.86,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":97.02,"profit":true}]
Income Taxes	-	(99.35%)	7285.45%	(72.26%)	(87.93%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-1.36,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-0.99,"profit":false},{"date":"2025-12-31","value":-1.21,"profit":false}]
Income After Taxes	-	34.45%	37.02%	41.33%	39.06%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":83.35,"profit":true},{"date":"2023-12-31","value":89.58,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":94.5,"profit":true}]

Income From Continuous Operations	-	28.42%	22.17%	58.48%	39.06%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":48.6,"profit":true},{"date":"2023-12-31","value":37.9,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":66.79,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income	-	34.45%	37.02%	41.33%	39.06%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":83.35,"profit":true},{"date":"2023-12-31","value":89.58,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":94.5,"profit":true}]

EPS (Diluted)	-	(40.43%)	14.60%	5.73%	(10.84%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-276.98,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":39.27,"profit":true},{"date":"2025-12-31","value":-74.28,"profit":false}]

	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	TREND
Total Revenue	4.51M	14.74M	19.10M	5.17M	35.54M	[{"date":"2024-12-31","value":12.69,"profit":true},{"date":"2025-03-31","value":41.49,"profit":true},{"date":"2025-06-30","value":53.75,"profit":true},{"date":"2025-09-30","value":14.56,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Cost of Revenue	12.79M	21.83M	20.16M	29.59M	26.88M	[{"date":"2024-12-31","value":43.23,"profit":true},{"date":"2025-03-31","value":73.76,"profit":true},{"date":"2025-06-30","value":68.13,"profit":true},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":90.82,"profit":true}]
Gross Profit	(8.28M)	(7.08M)	(1.06M)	(24.42M)	8.66M	[{"date":"2024-12-31","value":-95.62,"profit":false},{"date":"2025-03-31","value":-81.78,"profit":false},{"date":"2025-06-30","value":-12.21,"profit":false},{"date":"2025-09-30","value":-281.9,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]
Gross Margin	(183.62%)	(48.04%)	(5.54%)	(471.85%)	24.37%	[{"date":"2024-12-31","value":-753.34,"profit":false},{"date":"2025-03-31","value":-197.11,"profit":false},{"date":"2025-06-30","value":-22.72,"profit":false},{"date":"2025-09-30","value":-1935.86,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]

Operating Expenses	175.49M	184.28M	175.17M	147.78M	117.00M	[{"date":"2024-12-31","value":95.23,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":95.05,"profit":true},{"date":"2025-09-30","value":80.19,"profit":true},{"date":"2025-12-31","value":63.49,"profit":true}]
Operating Income	(183.77M)	(191.37M)	(176.23M)	(172.20M)	(108.33M)	[{"date":"2024-12-31","value":-18376800000,"profit":false},{"date":"2025-03-31","value":-19136800000,"profit":false},{"date":"2025-06-30","value":-17622700000,"profit":false},{"date":"2025-09-30","value":-17220200000,"profit":false},{"date":"2025-12-31","value":-10833400000,"profit":false}]
Total Non-Operating Income/Expense	8.88M	(6.23M)	9.29M	14.66M	6.49M	[{"date":"2024-12-31","value":60.6,"profit":true},{"date":"2025-03-31","value":-42.48,"profit":false},{"date":"2025-06-30","value":63.39,"profit":true},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":44.27,"profit":true}]
Pre-Tax Income	(178.90M)	(202.65M)	(171.90M)	(162.25M)	(108.10M)	[{"date":"2024-12-31","value":-17889900000,"profit":false},{"date":"2025-03-31","value":-20264500000,"profit":false},{"date":"2025-06-30","value":-17189700000,"profit":false},{"date":"2025-09-30","value":-16225000000,"profit":false},{"date":"2025-12-31","value":-10810200000,"profit":false}]
Income Taxes	7.00K	(158.00K)	-	3.00K	20.00K	[{"date":"2024-12-31","value":35,"profit":true},{"date":"2025-03-31","value":-790,"profit":false},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":15,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Income After Taxes	(178.91M)	(202.49M)	-	(162.25M)	(108.12M)	[{"date":"2024-12-31","value":-17890600000,"profit":false},{"date":"2025-03-31","value":-20248700000,"profit":false},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":-16225300000,"profit":false},{"date":"2025-12-31","value":-10812200000,"profit":false}]

Income From Continuous Operations	(178.91M)	(202.49M)	(171.90M)	(162.25M)	(108.12M)	[{"date":"2024-12-31","value":-17890600000,"profit":false},{"date":"2025-03-31","value":-20248700000,"profit":false},{"date":"2025-06-30","value":-17189700000,"profit":false},{"date":"2025-09-30","value":-16225300000,"profit":false},{"date":"2025-12-31","value":-10812100000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income	(178.91M)	(202.49M)	(171.90M)	(162.25M)	(108.12M)	[{"date":"2024-12-31","value":-17890600000,"profit":false},{"date":"2025-03-31","value":-20248700000,"profit":false},{"date":"2025-06-30","value":-17189700000,"profit":false},{"date":"2025-09-30","value":-16225300000,"profit":false},{"date":"2025-12-31","value":-10812400000,"profit":false}]

EPS (Diluted)	(0.53)	(0.50)	(0.41)	(0.36)	(0.21)	[{"date":"2024-12-31","value":-53,"profit":false},{"date":"2025-03-31","value":-50,"profit":false},{"date":"2025-06-30","value":-41,"profit":false},{"date":"2025-09-30","value":-36,"profit":false},{"date":"2025-12-31","value":-21,"profit":false}]

	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	TREND
Total Revenue	-	226.87%	29.56%	(72.91%)	586.72%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":38.67,"profit":true},{"date":"2025-06-30","value":5.04,"profit":true},{"date":"2025-09-30","value":-12.43,"profit":false},{"date":"2025-12-31","value":100,"profit":true}]
Cost of Revenue	-	70.62%	(7.64%)	46.78%	(9.18%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-10.82,"profit":false},{"date":"2025-09-30","value":66.25,"profit":true},{"date":"2025-12-31","value":-13,"profit":false}]
Gross Profit	-	(14.48%)	(85.06%)	2207.94%	(135.47%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-0.66,"profit":false},{"date":"2025-06-30","value":-3.85,"profit":false},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":-6.14,"profit":false}]
Gross Margin	-	(73.84%)	(88.47%)	8419.53%	(105.17%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-0.88,"profit":false},{"date":"2025-06-30","value":-1.05,"profit":false},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":-1.25,"profit":false}]

Operating Expenses	-	5.01%	(4.95%)	(15.63%)	(20.83%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-98.65,"profit":false},{"date":"2025-09-30","value":-311.79,"profit":false},{"date":"2025-12-31","value":-415.49,"profit":false}]
Operating Income	-	4.14%	(7.91%)	(2.28%)	(37.09%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-191.31,"profit":false},{"date":"2025-09-30","value":-55.23,"profit":false},{"date":"2025-12-31","value":-896.81,"profit":false}]
Total Non-Operating Income/Expense	-	(170.09%)	(249.24%)	57.74%	(55.73%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-294.57,"profit":false},{"date":"2025-06-30","value":-431.64,"profit":false},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":-96.51,"profit":false}]
Pre-Tax Income	-	13.27%	(15.17%)	(5.61%)	(33.37%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-114.31,"profit":false},{"date":"2025-09-30","value":-42.28,"profit":false},{"date":"2025-12-31","value":-251.43,"profit":false}]
Income Taxes	-	(2357.14%)	-	-	566.67%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-415.97,"profit":false},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Income After Taxes	-	13.18%	-	-	(33.36%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true},{"date":"2025-12-31","value":-253.11,"profit":false}]

Income From Continuous Operations	-	13.18%	(15.11%)	(5.61%)	(33.36%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-114.62,"profit":false},{"date":"2025-09-30","value":-42.56,"profit":false},{"date":"2025-12-31","value":-253.12,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income	-	13.18%	(15.11%)	(5.61%)	(33.36%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-114.62,"profit":false},{"date":"2025-09-30","value":-42.56,"profit":false},{"date":"2025-12-31","value":-253.1,"profit":false}]

EPS (Diluted)	-	(5.66%)	(18.00%)	(12.20%)	(41.67%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false},{"date":"2025-12-31","value":null,"profit":false}]

	Dec '21	Dec '22	Dec '23	Dec '24	Dec '25	5YR TREND
Total Assets
Current Assets	534.72M	569.81M	438.14M	714.27M	812.85M	[{"date":"2021-12-31","value":65.78,"profit":true},{"date":"2022-12-31","value":70.1,"profit":true},{"date":"2023-12-31","value":53.9,"profit":true},{"date":"2024-12-31","value":87.87,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Non-current Assets	75.63M	131.47M	215.56M	734.33M	661.28M	[{"date":"2021-12-31","value":10.3,"profit":true},{"date":"2022-12-31","value":17.9,"profit":true},{"date":"2023-12-31","value":29.35,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":90.05,"profit":true}]
Total Assets	610.35M	701.29M	653.70M	1.45B	1.47B	[{"date":"2021-12-31","value":41.4,"profit":true},{"date":"2022-12-31","value":47.57,"profit":true},{"date":"2023-12-31","value":44.34,"profit":true},{"date":"2024-12-31","value":98.27,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	46.66M	100.27M	93.17M	187.47M	147.71M	[{"date":"2021-12-31","value":24.89,"profit":true},{"date":"2022-12-31","value":53.48,"profit":true},{"date":"2023-12-31","value":49.7,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":78.79,"profit":true}]
Non-current Liabilities	20.75M	115.22M	97.09M	226.34M	195.56M	[{"date":"2021-12-31","value":9.17,"profit":true},{"date":"2022-12-31","value":50.9,"profit":true},{"date":"2023-12-31","value":42.9,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":86.4,"profit":true}]
Total Liabilities	67.41M	215.48M	190.26M	413.82M	343.26M	[{"date":"2021-12-31","value":16.29,"profit":true},{"date":"2022-12-31","value":52.07,"profit":true},{"date":"2023-12-31","value":45.98,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":82.95,"profit":true}]

Total Shareholders' equity
Common Stock	2.00K	2.00K	2.00K	4.00K	5.00K	[{"date":"2021-12-31","value":40,"profit":true},{"date":"2022-12-31","value":40,"profit":true},{"date":"2023-12-31","value":40,"profit":true},{"date":"2024-12-31","value":80,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Retained Earnings	(400.08M)	(639.56M)	(967.62M)	(1.43B)	(2.08B)	[{"date":"2021-12-31","value":-40008000000,"profit":false},{"date":"2022-12-31","value":-63955600000,"profit":false},{"date":"2023-12-31","value":-96762200000,"profit":false},{"date":"2024-12-31","value":-143128300000,"profit":false},{"date":"2025-12-31","value":-207600200000,"profit":false}]
Other Stockholders' Equity	943.14M	1.13B	1.43B	2.47B	3.17B	[{"date":"2021-12-31","value":29.75,"profit":true},{"date":"2022-12-31","value":35.5,"profit":true},{"date":"2023-12-31","value":45.14,"profit":true},{"date":"2024-12-31","value":78.03,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Total Shareholders' equity	542.94M	485.81M	463.44M	1.03B	1.13B	[{"date":"2021-12-31","value":48.01,"profit":true},{"date":"2022-12-31","value":42.96,"profit":true},{"date":"2023-12-31","value":40.98,"profit":true},{"date":"2024-12-31","value":91.5,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	610.35M	701.29M	653.70M	1.45B	1.47B	[{"date":"2021-12-31","value":41.4,"profit":true},{"date":"2022-12-31","value":47.57,"profit":true},{"date":"2023-12-31","value":44.34,"profit":true},{"date":"2024-12-31","value":98.27,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

	Dec '21	Dec '22	Dec '23	Dec '24	Dec '25	5YR TREND
Total Assets
Current Assets	-	6.56%	(23.11%)	63.02%	13.80%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":10.41,"profit":true},{"date":"2023-12-31","value":-36.67,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":21.9,"profit":true}]
Non-current Assets	-	73.85%	63.96%	240.66%	(9.95%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":30.68,"profit":true},{"date":"2023-12-31","value":26.58,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":-4.13,"profit":false}]
Total Assets	-	14.90%	(6.79%)	121.60%	1.76%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":12.25,"profit":true},{"date":"2023-12-31","value":-5.58,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":1.45,"profit":true}]

Total Liabilities
Current Liabilities	-	114.89%	(7.08%)	101.21%	(21.21%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-6.16,"profit":false},{"date":"2024-12-31","value":88.09,"profit":true},{"date":"2025-12-31","value":-18.46,"profit":false}]
Non-current Liabilities	-	455.29%	(15.73%)	133.12%	(13.60%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-3.46,"profit":false},{"date":"2024-12-31","value":29.24,"profit":true},{"date":"2025-12-31","value":-2.99,"profit":false}]
Total Liabilities	-	219.67%	(11.70%)	117.50%	(17.05%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-5.33,"profit":false},{"date":"2024-12-31","value":53.49,"profit":true},{"date":"2025-12-31","value":-7.76,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	-	100.00%	25.00%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":25,"profit":true}]
Retained Earnings	-	59.86%	51.30%	47.92%	45.04%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":85.7,"profit":true},{"date":"2024-12-31","value":80.05,"profit":true},{"date":"2025-12-31","value":75.25,"profit":true}]
Other Stockholders' Equity	-	19.32%	27.16%	72.86%	28.15%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":26.52,"profit":true},{"date":"2023-12-31","value":37.28,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":38.64,"profit":true}]
Total Shareholders' equity	-	(10.52%)	(4.60%)	123.28%	9.29%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-8.54,"profit":false},{"date":"2023-12-31","value":-3.74,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":7.53,"profit":true}]

Total Liabilities & Shareholders Equity	-	14.90%	(6.79%)	121.60%	1.76%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":12.25,"profit":true},{"date":"2023-12-31","value":-5.58,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":1.45,"profit":true}]

	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	TREND
Total Assets
Current Assets	714.27M	584.14M	587.16M	714.11M	812.85M	[{"date":"2024-12-31","value":87.87,"profit":true},{"date":"2025-03-31","value":71.86,"profit":true},{"date":"2025-06-30","value":72.24,"profit":true},{"date":"2025-09-30","value":87.85,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Non-current Assets	734.33M	721.09M	715.20M	685.42M	661.28M	[{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":98.2,"profit":true},{"date":"2025-06-30","value":97.39,"profit":true},{"date":"2025-09-30","value":93.34,"profit":true},{"date":"2025-12-31","value":90.05,"profit":true}]
Total Assets	1.45B	1.31B	1.30B	1.40B	1.47B	[{"date":"2024-12-31","value":98.27,"profit":true},{"date":"2025-03-31","value":88.54,"profit":true},{"date":"2025-06-30","value":88.35,"profit":true},{"date":"2025-09-30","value":94.94,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	187.47M	141.98M	164.03M	155.10M	147.71M	[{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":75.73,"profit":true},{"date":"2025-06-30","value":87.49,"profit":true},{"date":"2025-09-30","value":82.73,"profit":true},{"date":"2025-12-31","value":78.79,"profit":true}]
Non-current Liabilities	226.34M	229.31M	219.18M	197.47M	195.56M	[{"date":"2024-12-31","value":98.71,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":95.59,"profit":true},{"date":"2025-09-30","value":86.12,"profit":true},{"date":"2025-12-31","value":85.28,"profit":true}]
Total Liabilities	413.82M	371.29M	383.21M	352.58M	343.26M	[{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":89.72,"profit":true},{"date":"2025-06-30","value":92.6,"profit":true},{"date":"2025-09-30","value":85.2,"profit":true},{"date":"2025-12-31","value":82.95,"profit":true}]

Total Shareholders' equity
Common Stock	4.00K	4.00K	4.00K	5.00K	5.00K	[{"date":"2024-12-31","value":80,"profit":true},{"date":"2025-03-31","value":80,"profit":true},{"date":"2025-06-30","value":80,"profit":true},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Retained Earnings	(1.43B)	(1.63B)	(1.81B)	(1.97B)	(2.08B)	[{"date":"2024-12-31","value":-143128300000,"profit":false},{"date":"2025-03-31","value":-163369400000,"profit":false},{"date":"2025-06-30","value":-180558900000,"profit":false},{"date":"2025-09-30","value":-196787900000,"profit":false},{"date":"2025-12-31","value":-207600200000,"profit":false}]
Other Stockholders' Equity	2.47B	2.55B	2.68B	2.98B	3.17B	[{"date":"2024-12-31","value":78.03,"profit":true},{"date":"2025-03-31","value":80.55,"profit":true},{"date":"2025-06-30","value":84.57,"profit":true},{"date":"2025-09-30","value":94.03,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Total Shareholders' equity	1.03B	933.95M	919.15M	1.05B	1.13B	[{"date":"2024-12-31","value":91.5,"profit":true},{"date":"2025-03-31","value":82.59,"profit":true},{"date":"2025-06-30","value":81.28,"profit":true},{"date":"2025-09-30","value":92.58,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	1.45B	1.31B	1.30B	1.40B	1.47B	[{"date":"2024-12-31","value":98.27,"profit":true},{"date":"2025-03-31","value":88.54,"profit":true},{"date":"2025-06-30","value":88.35,"profit":true},{"date":"2025-09-30","value":94.94,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	TREND
Total Assets
Current Assets	-	(18.22%)	0.52%	21.62%	13.83%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-84.26,"profit":false},{"date":"2025-06-30","value":2.39,"profit":true},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":63.95,"profit":true}]
Non-current Assets	-	(1.80%)	(0.82%)	(4.16%)	(3.52%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false},{"date":"2025-12-31","value":null,"profit":false}]
Total Assets	-	(9.90%)	(0.22%)	7.46%	5.33%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-132.64,"profit":false},{"date":"2025-06-30","value":-2.96,"profit":false},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":71.45,"profit":true}]

Total Liabilities
Current Liabilities	-	(24.27%)	15.53%	(5.44%)	(4.77%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-156.28,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-35.04,"profit":false},{"date":"2025-12-31","value":-30.71,"profit":false}]
Non-current Liabilities	-	1.31%	(4.41%)	(9.90%)	(0.97%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-337.35,"profit":false},{"date":"2025-09-30","value":-756.83,"profit":false},{"date":"2025-12-31","value":-74.18,"profit":false}]
Total Liabilities	-	(10.28%)	3.21%	(7.99%)	(2.64%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-320.07,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-248.94,"profit":false},{"date":"2025-12-31","value":-82.26,"profit":false}]

Total Shareholders' equity
Common Stock	-	-	-	25.00%	-	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Retained Earnings	-	14.14%	10.52%	8.99%	5.49%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":74.4,"profit":true},{"date":"2025-09-30","value":63.56,"profit":true},{"date":"2025-12-31","value":38.85,"profit":true}]
Other Stockholders' Equity	-	3.23%	5.00%	11.18%	6.35%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":28.86,"profit":true},{"date":"2025-06-30","value":44.72,"profit":true},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":56.86,"profit":true}]
Total Shareholders' equity	-	(9.74%)	(1.58%)	13.90%	8.02%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-70.08,"profit":false},{"date":"2025-06-30","value":-11.4,"profit":false},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":57.65,"profit":true}]

Total Liabilities & Shareholders Equity	-	(9.90%)	(0.22%)	7.46%	5.33%	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-132.64,"profit":false},{"date":"2025-06-30","value":-2.96,"profit":false},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":71.45,"profit":true}]

	Dec '21	Dec '22	Dec '23	Dec '24	Dec '25	5YR TREND
Operating Activities
Net Operating Cash Flow	(158.61M)	(83.52M)	(287.78M)	(359.17M)	(371.81M)	[{"date":"2021-12-31","value":-15861400000,"profit":false},{"date":"2022-12-31","value":-8352400000,"profit":false},{"date":"2023-12-31","value":-28778000000,"profit":false},{"date":"2024-12-31","value":-35917400000,"profit":false},{"date":"2025-12-31","value":-37180800000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(271.74M)	193.25M	(10.23M)	260.06M	(16.87M)	[{"date":"2021-12-31","value":-104.49,"profit":false},{"date":"2022-12-31","value":74.31,"profit":true},{"date":"2023-12-31","value":-3.93,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":-6.49,"profit":false}]

Financing Activities
Net Financing Cash Flow	458.54M	154.34M	140.13M	304.12M	521.53M	[{"date":"2021-12-31","value":87.92,"profit":true},{"date":"2022-12-31","value":29.59,"profit":true},{"date":"2023-12-31","value":26.87,"profit":true},{"date":"2024-12-31","value":58.31,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

Net Change in Cash	28.18M	263.76M	(157.69M)	201.60M	150.90M	[{"date":"2021-12-31","value":10.68,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-59.78,"profit":false},{"date":"2024-12-31","value":76.43,"profit":true},{"date":"2025-12-31","value":57.21,"profit":true}]

Free Cash Flow
Free Cash Flow	(198.41M)	(120.88M)	(299.74M)	(372.87M)	(378.28M)	[{"date":"2021-12-31","value":-19841200000,"profit":false},{"date":"2022-12-31","value":-12088300000,"profit":false},{"date":"2023-12-31","value":-29973500000,"profit":false},{"date":"2024-12-31","value":-37286900000,"profit":false},{"date":"2025-12-31","value":-37827700000,"profit":false}]

	Dec '21	Dec '22	Dec '23	Dec '24	Dec '25	5YR TREND
Operating Activities
Net Operating Cash Flow	-	(47.34%)	244.55%	24.81%	3.52%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-19.36,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":10.14,"profit":true},{"date":"2025-12-31","value":1.44,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(171.11%)	(105.29%)	(2642.62%)	(106.49%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-12-31","value":null,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	(66.34%)	(9.21%)	117.02%	71.49%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-56.69,"profit":false},{"date":"2023-12-31","value":-7.87,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":61.09,"profit":true}]

Net Change in Cash	-	835.93%	(159.78%)	(227.85%)	(25.15%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-19.11,"profit":false},{"date":"2024-12-31","value":-27.26,"profit":false},{"date":"2025-12-31","value":-3.01,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(39.07%)	147.95%	24.40%	1.45%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-26.41,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":16.49,"profit":true},{"date":"2025-12-31","value":0.98,"profit":true}]

	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	TREND
Operating Activities
Net Operating Cash Flow	(115.43M)	(131.96M)	(76.42M)	(117.36M)	(46.07M)	[{"date":"2024-12-31","value":-11543000000,"profit":false},{"date":"2025-03-31","value":-13195700000,"profit":false},{"date":"2025-06-30","value":-7641800000,"profit":false},{"date":"2025-09-30","value":-11736000000,"profit":false},{"date":"2025-12-31","value":-4607300000,"profit":false}]

Investing Activities
Net Investing Cash Flow	275.46M	(7.27M)	(5.81M)	(2.55M)	(1.24M)	[{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-2.64,"profit":false},{"date":"2025-06-30","value":-2.11,"profit":false},{"date":"2025-09-30","value":-0.93,"profit":false},{"date":"2025-12-31","value":-0.45,"profit":false}]

Financing Activities
Net Financing Cash Flow	10.64M	40.53M	97.66M	251.34M	132.01M	[{"date":"2024-12-31","value":4.23,"profit":true},{"date":"2025-03-31","value":16.12,"profit":true},{"date":"2025-06-30","value":38.86,"profit":true},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":52.52,"profit":true}]

Net Change in Cash	167.19M	(93.87M)	24.69M	133.30M	86.78M	[{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-56.14,"profit":false},{"date":"2025-06-30","value":14.77,"profit":true},{"date":"2025-09-30","value":79.73,"profit":true},{"date":"2025-12-31","value":51.9,"profit":true}]

Free Cash Flow
Free Cash Flow	(117.08M)	(133.79M)	(79.57M)	(117.60M)	(47.32M)	[{"date":"2024-12-31","value":-11707800000,"profit":false},{"date":"2025-03-31","value":-13378900000,"profit":false},{"date":"2025-06-30","value":-7956800000,"profit":false},{"date":"2025-09-30","value":-11760300000,"profit":false},{"date":"2025-12-31","value":-4731700000,"profit":false}]

	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	TREND
Operating Activities
Net Operating Cash Flow	-	14.32%	(42.09%)	53.58%	(60.74%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":26.72,"profit":true},{"date":"2025-06-30","value":-78.56,"profit":false},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":-113.37,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	(102.64%)	(20.11%)	(56.11%)	(51.20%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false},{"date":"2025-12-31","value":null,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	280.93%	140.97%	157.36%	(47.48%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":50.18,"profit":true},{"date":"2025-09-30","value":56.02,"profit":true},{"date":"2025-12-31","value":-16.9,"profit":false}]

Net Change in Cash	-	(156.14%)	(126.30%)	439.94%	(34.90%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":-35.49,"profit":false},{"date":"2025-06-30","value":-28.71,"profit":false},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":-7.93,"profit":false}]

Free Cash Flow
Free Cash Flow	-	14.27%	(40.53%)	47.80%	(59.77%)	[{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":29.86,"profit":true},{"date":"2025-06-30","value":-84.78,"profit":false},{"date":"2025-09-30","value":100,"profit":true},{"date":"2025-12-31","value":-125.03,"profit":false}]

Recursion Pharmaceuticals Inc Ratios

Recursion Pharmaceuticals Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	RXRX
Cash Ratio	5.03
Current Ratio	5.50

Recursion Pharmaceuticals Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	RXRX
ROA (LTM)	-27.72%
ROE (LTM)	-59.54%

Recursion Pharmaceuticals Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	RXRX
Debt Ratio Lower is generally better. Negative is bad.	0.23
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.77

Recursion Pharmaceuticals Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	RXRX
Trailing PE	NM
Forward PE	NM
P/S (TTM)	24.40
P/B	1.61
Price/FCF	NM
EV/R	15.58
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Recursion Pharmaceuticals Inc share price today?

Recursion Pharmaceuticals Inc (RXRX) share price today is $3.4

Can Indians buy Recursion Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Recursion Pharmaceuticals Inc (RXRX) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RXRX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Recursion Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Recursion Pharmaceuticals Inc (RXRX) via the Vested app. You can start investing in Recursion Pharmaceuticals Inc (RXRX) with a minimum investment of $1.

How to invest in Recursion Pharmaceuticals Inc shares from India?

You can invest in shares of Recursion Pharmaceuticals Inc (RXRX) via Vested in three simple steps:

Click on Sign Up or Invest in RXRX stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Recursion Pharmaceuticals Inc shares

What is Recursion Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Recursion Pharmaceuticals Inc (RXRX) is $7.18. The 52-week low price of Recursion Pharmaceuticals Inc (RXRX) is $2.98.

What is Recursion Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Recursion Pharmaceuticals Inc (RXRX) is

What is Recursion Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Recursion Pharmaceuticals Inc (RXRX) is 1.61

What is Recursion Pharmaceuticals Inc dividend yield?

The dividend yield of Recursion Pharmaceuticals Inc (RXRX) is 0.00%

What is the Market Cap of Recursion Pharmaceuticals Inc?

The market capitalization of Recursion Pharmaceuticals Inc (RXRX) is $1.74B

What is Recursion Pharmaceuticals Inc's stock symbol?

The stock symbol (or ticker) of Recursion Pharmaceuticals Inc is RXRX

How Can Investors Use Recursion Pharmaceuticals Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Recursion Pharmaceuticals Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Recursion Pharmaceuticals Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Recursion Pharmaceuticals Inc shares for Indian investors?

When investing in Recursion Pharmaceuticals Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Recursion Pharmaceuticals Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Recursion Pharmaceuticals Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Recursion Pharmaceuticals Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Recursion Pharmaceuticals Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Recursion Pharmaceuticals Inc Share Price

Recursion Pharmaceuticals Inc Analyst Forecast

Recursion Pharmaceuticals Inc Share Price Chart

Recursion Pharmaceuticals Inc Key Stock Metrics

About Recursion Pharmaceuticals Inc, Common Stock

Recursion Pharmaceuticals Inc Stock Returns

Recursion Pharmaceuticals Inc Financials

Recursion Pharmaceuticals Inc Ratios

Recursion Pharmaceuticals Inc Liquidity Ratios

Recursion Pharmaceuticals Inc Asset Efficiency Ratios

Recursion Pharmaceuticals Inc Liability Ratios

Recursion Pharmaceuticals Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Recursion Pharmaceuticals Inc Share Price

Recursion Pharmaceuticals Inc Analyst Forecast

Recursion Pharmaceuticals Inc Share Price Chart

Recursion Pharmaceuticals Inc Key Stock Metrics

About Recursion Pharmaceuticals Inc, Common Stock

Recursion Pharmaceuticals Inc Stock Returns

Recursion Pharmaceuticals Inc Financials

Recursion Pharmaceuticals Inc Ratios

Recursion Pharmaceuticals Inc Liquidity Ratios

Recursion Pharmaceuticals Inc Asset Efficiency Ratios

Recursion Pharmaceuticals Inc Liability Ratios

Recursion Pharmaceuticals Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²